ABREVA Rapid Pain Relief
NDC 0135-0400, glycerin, lidocaine, gel, from Haleon US Holdings LLC.
- Product NDC
- 0135-0400
- Status
- Listed
- Labeler
- Haleon US Holdings LLC
- Dosage form
- GEL
- Route
- TOPICAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- OTC MONOGRAPH DRUG
- Application
- M017
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0135-0400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLYCERIN200 mg/g
- LIDOCAINE HYDROCHLORIDE40 mg/g
Pharmacologic classes
Allergens [CS]; Amide Local Anesthetic [EPC]; Amides [CS]; Antiarrhythmic [EPC]; Cell-mediated Immunity [PE]; Glycerol [CS]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Local Anesthesia [PE]; Non-Standardized Chemical Allergen [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0135-0400-01 | 00135040001 | 1 TUBE in 1 PACKAGE (0135-0400-01) / 3 g in 1 TUBE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0135-0400 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0135-0400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0135-0400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.